Access Resources
7151 - 7200 of 7540 Results
Title
Year
- Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?2011RESTRICTEDTitle: Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?Journal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 69Issue #: 2Start Page: 357End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3182160456Best OA location URL: https://europepmc.org/articles/pmc3593636?pdf=renderCitation Count: 22
- Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice2011RESTRICTEDTitle: Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent miceJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 47Issue #: 4Start Page: 286End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2011.05.006Best OA location URL: https://europepmc.org/articles/pmc3149813?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: The cholinergic system and Parkinson diseaseJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 221Issue #: 2Start Page: 564End Page: 573Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2009.12.048Best OA location URL: https://europepmc.org/articles/pmc2888997?pdf=renderCitation Count: 437
-
RESTRICTEDTitle: Olfactory dysfunction in LRRK2 G2019S mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 4Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318227041cBest OA location URL: https://europepmc.org/articles/pmc3140803?pdf=renderCitation Count: 57
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia2011RESTRICTEDTitle: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2339End Page: 2357Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awr165Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2339/13735225/awr165.pdfCitation Count: 113
- Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics2011RESTRICTEDTitle: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 39End Page: 52Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-011-0682-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdfCitation Count: 66
-
RESTRICTEDTitle: Quantitative EEG as a predictive biomarker for Parkinson disease dementiaJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 2Start Page: 118End Page: 124Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318224af8dBest OA location URL: https://europepmc.org/articles/pmc3140072?pdf=renderCitation Count: 176
-
RESTRICTEDTitle: Obesity, diabetes, and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2253End Page: 2259Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23855Best OA location URL: https://europepmc.org/articles/pmc3627531?pdf=renderCitation Count: 129
- Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment2011RESTRICTEDTitle: Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive ImpairmentJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 5Start Page: 455End Page: 463Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-011-0212-0Best OA location URL: https://europepmc.org/articles/pmc3213691?pdf=renderCitation Count: 9
- Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndrome2011RESTRICTEDTitle: Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 456End Page: 458Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.03.007Best OA location URL: https://europepmc.org/articles/pmc3119772?pdf=renderCitation Count: 75
-
RESTRICTEDTitle: VPS35 Mutations in Parkinson DiseaseJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 89Issue #: 1Start Page: 162End Page: 167Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2011.06.001Best OA location URL: http://www.cell.com/article/S0002929711002424/pdfCitation Count: 747
-
RESTRICTEDTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: https://europepmc.org/articles/pmc4216677?pdf=renderCitation Count: 61
- Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease2011RESTRICTEDTitle: Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's DiseaseJournal Name: PLoS GeneticsPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 6Start Page: e1002141End Page: e1002141Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1002141Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1002141&type=printableCitation Count: 473
-
RESTRICTEDTitle: Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2358End Page: 2365Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awr139Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2358/1015592/awr139.pdfCitation Count: 103
-
RESTRICTEDTitle: Diagnosis and Referral Delay in Women With Parkinson's DiseaseJournal Name: Gender MedicinePublisher: Elsevier BVVol: 8Issue #: 3Start Page: 209End Page: 217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.genm.2011.05.002Best OA location URL: https://europepmc.org/articles/pmc3966522?pdf=renderCitation Count: 46
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease2011RESTRICTEDTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/search/files/1732507/1885514.pdfCitation Count: 149
-
RESTRICTEDTitle: Inclusion and exclusion criteria for DBS in dystoniaJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23482Best OA location URL: https://europepmc.org/articles/pmc8478120?pdf=renderCitation Count: 57
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease2011RESTRICTEDTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 117
- Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?2011RESTRICTEDTitle: Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 5Start Page: 365End Page: 371Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.02.017Best OA location URL: https://europepmc.org/articles/pmc3109165?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: Transcription Factor-Induced Lineage Selection of Stem-Cell-Derived Neural Progenitor CellsJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 8Issue #: 6Start Page: 663End Page: 675Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.stem.2011.04.001Best OA location URL: http://www.cell.com/article/S1934590911001664/pdfCitation Count: 63
-
RESTRICTEDTitle: Utilising functional MRI (fMRI) to explore the freezing phenomenon in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 18Issue #: 6Start Page: 807End Page: 810Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2011.02.003Citation Count: 32
-
RESTRICTEDTitle: Stress and the risk of multiple sclerosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 22Start Page: 1866End Page: 1871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31821d74c5Best OA location URL: https://europepmc.org/articles/pmc3115807?pdf=renderCitation Count: 56
-
RESTRICTEDTitle: Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 10Start Page: 1875End Page: 1880Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23746Best OA location URL: https://europepmc.org/articles/pmc3972755?pdf=renderCitation Count: 33
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011RESTRICTEDTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Best OA location URL: https://europepmc.org/articles/pmc3168697?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: A family with parkinsonism, essential tremor, restless legs syndrome, and depressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 19Start Page: 1623End Page: 1630Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318219fb42Best OA location URL: https://europepmc.org/articles/pmc3100088?pdf=renderCitation Count: 26
-
RESTRICTEDTitle: PD biomarkers—use of α-synuclein reaches new levelsJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 6Start Page: 308End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2011.66Best OA location URL: https://europepmc.org/articles/pmc4043344?pdf=renderCitation Count: 1
-
RESTRICTEDTitle: Group patient visits for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 18Start Page: 1542End Page: 1547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194badBest OA location URL: https://europepmc.org/articles/pmc3100128?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://europepmc.org/articles/pmc3154995?pdf=renderCitation Count: 19
-
RESTRICTEDTitle: Abnormal calcium homeostasis and protein folding stress at the ERJournal Name: Communicative & Integrative BiologyPublisher: Informa UK LimitedVol: 4Issue #: 3Start Page: 258End Page: 261Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.4161/cib.4.3.15019Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/cib.4.3.15019?needAccess=true&role=buttonCitation Count: 34
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats2011RESTRICTEDTitle: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 6Start Page: 861End Page: 868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032Best OA location URL: https://europepmc.org/articles/pmc3133531?pdf=renderCitation Count: 70
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures2011RESTRICTEDTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Best OA location URL: https://europepmc.org/articles/pmc3376651?pdf=renderCitation Count: 232
- Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease2011RESTRICTEDTitle: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 122Issue #: 1Start Page: 49End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1Best OA location URL: https://europepmc.org/articles/pmc3362487?pdf=renderCitation Count: 78
- Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion2011RESTRICTEDTitle: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 124Issue #: 9Start Page: 1403End Page: 1410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.079293Best OA location URL: https://europepmc.org/articles/pmc3078809Citation Count: 66
-
RESTRICTEDTitle: Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 4Issue #: 1Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.11001Best OA location URL: https://doi.org/10.14802/jmd.11001Citation Count: 15
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications2011RESTRICTEDTitle: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applicationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1386End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23737Best OA location URL: https://europepmc.org/articles/pmc3150637?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Priorities in Parkinson's disease researchJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 10Issue #: 5Start Page: 377End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrd3430Citation Count: 369
-
RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 36
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations2011RESTRICTEDTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://europepmc.org/articles/pmc3142314?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: A Genome-Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6Journal Name: Annals of Human GeneticsPublisher: WileyVol: 75Issue #: 3Start Page: 351End Page: 358Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.xBest OA location URL: https://europepmc.org/articles/pmc3077806?pdf=renderCitation Count: 10
- Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure2011RESTRICTEDTitle: Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposureJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 15Start Page: 1296End Page: 1301Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182152830Best OA location URL: https://europepmc.org/articles/pmc3090062?pdf=renderCitation Count: 79
-
RESTRICTEDTitle: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 4Start Page: 488End Page: 488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.53Best OA location URL: https://europepmc.org/articles/pmc3160280?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: S-Nitrosylation of ApoE in Alzheimer’s DiseaseJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 50Issue #: 17Start Page: 3405End Page: 3407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi200266vBest OA location URL: https://europepmc.org/articles/pmc3082618?pdf=renderCitation Count: 37
-
RESTRICTEDTitle: Methylphenidate for gait impairment in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 14Start Page: 1256End Page: 1262Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182143537Best OA location URL: https://europepmc.org/articles/pmc3068005?pdf=renderCitation Count: 83
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy2011RESTRICTEDTitle: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 178Issue #: 4Start Page: 1509End Page: 1516Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006Best OA location URL: http://ajp.amjpathol.org/article/S0002944011000575/pdfCitation Count: 102
- Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease2011RESTRICTEDTitle: Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 33Issue #: 9Start Page: 1598End Page: 1610Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2011.07660.xBest OA location URL: https://europepmc.org/articles/pmc3086951?pdf=renderCitation Count: 111
-
RESTRICTEDTitle: Molecular insights into Parkinson's diseaseJournal Name: F1000 Medicine ReportsPublisher: Faculty Opinions LtdVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3410/m3-7Best OA location URL: https://connect.h1.co/prime/reports/m/3/7/pdfCitation Count: 46
- β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway2011RESTRICTEDTitle: β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling PathwayJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 186Issue #: 7Start Page: 4443End Page: 4454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.1002449Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/186/7/4443/1340946/1002449.pdfCitation Count: 102
-
RESTRICTEDTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://europepmc.org/articles/pmc3140626?pdf=renderCitation Count: 7
- Tremor severity and age: A cross‐sectional, population‐based study of 2,524 young and midlife normal adults2011RESTRICTEDTitle: Tremor severity and age: A cross‐sectional, population‐based study of 2,524 young and midlife normal adultsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1515End Page: 1520Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23674Best OA location URL: https://europepmc.org/articles/pmc5927551?pdf=renderCitation Count: 9
-
RESTRICTEDTitle: Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 7Issue #: 4Start Page: 436End Page: 444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2010.08.228Best OA location URL: https://europepmc.org/articles/pmc3117084?pdf=renderCitation Count: 105